The Journal of Infectious Diseases
Oxford University Press
image
Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing
DOI 10.1093/infdis/jiab198 , Volume: 224 , Issue: 4 , Pages: 741-745
Article Type: correction, Article History

Highlights

Notes

In “SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing” by Rathe et al. [J Infect Dis 2020; jiaa797], the advance online publication contained an error in Table 1, Figure 4B, and Figure 5 in which “sensitivity” and “specificity” labels were accidentally interchanged. The error was introduced when the labels were transferred from statistics software output to a master data file. The statistics remain the same and are correct. The corrected table and figures are provided below, and are correct in the printed version. The authors regret the error.

Original Table 1:

Specificity, % (95% CI) Sensitivity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
RBD IgG 87 (62–98) 100 (89–100) 100 (77–100) 94 (80–99)
RBD IgM 73 (48–89) 97 (83–100) 92 (65–100) 88 (73–95)
Spike IgG 67 (42–85) 97 (83–100) 91 (62–100) 85 (70–94)
Spike IgM 60 (36–80) 97 (83–100) 90 (60–100) 83 (67–92)
Spike IgG1 71 (45–88) 100 (87–100) 100 (72–100) 88 (73–95)
Spike IgG3 93 (70–100) 97 (83–100) 93 (70–100) 97 (83–100)
Spike IgA 67 (42–85) 100 (89–100) 100 (72–100) 86 (71–94)
NP IgG 93 (70–100) 97 (83–100) 93 (70–100) 97 (83–100)

Corrected Table 1:

Platforms Sensitivity, % (95% CI) Specificity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
RBD IgG 87 (62–98) 100 (89–100) 100 (77–100) 94 (80–99)
RBD IgM 73 (48–89) 97 (83–100) 92 (65–100) 88 (73–95)
Spike IgG 67 (42–85) 97 (83–100) 91 (62–100) 85 (70–94)
Spike IgM 60 (36–80) 97 (83–100) 90 (60–100) 83 (67–92)
Spike IgG1 71 (45–88) 100 (87–100) 100 (72–100) 88 (73–95)
Spike IgG3 93 (70–100) 97 (83–100) 93 (70–100) 97 (83–100)
Spike IgA 67 (42–85) 100 (89–100) 100 (72–100) 86 (71–94)
NP IgG 93 (70–100) 97 (83–100) 93 (70–100) 97 (83–100)

Original Figure 4:

Corrected Figure 4:

Original Figure 5:

Corrected Figure 5:

https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

https://www.researchpad.co/tools/openurl?pubtype=article&doi=10.1093/infdis/jiab198&title=Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing&author=Jennifer A Rathe,Emily A Hemann,Julie Eggenberger,Zhaoqi Li,Megan L Knoll,Caleb Stokes,Tien-Ying Hsiang,Jason Netland,Kennidy K Takehara,Marion Pepper,Michael Gale,&keyword=&subject=Corrigenda,AcademicSubjects/MED00290,